Drug Shortage Report for TEVA-SALBUTAMOL STERINEBS P.F.

Last updated on 2025-11-06 History
Report ID 215707
Drug Identification Number 01926934
Brand name TEVA-SALBUTAMOL STERINEBS P.F.
Common or Proper name SALBUTAMOL 1MG/ML NEBS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SALBUTAMOL
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging size 20 X 2.5ML
ATC code R03AC
ATC description ADRENERGICS, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-01-10
Estimated end date 2025-11-07
Actual end date 2025-11-05
Shortage status Resolved
Updated date 2025-11-06
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v39 2025-11-06 French Compare
v38 2025-11-06 English Compare
v37 2025-11-03 French Compare
v36 2025-11-03 English Compare
v35 2025-10-23 French Compare
v34 2025-10-23 English Compare
v33 2025-10-16 French Compare
v32 2025-10-16 English Compare
v31 2025-10-10 French Compare
v30 2025-10-10 English Compare
v29 2025-10-02 French Compare
v28 2025-10-02 English Compare
v27 2025-09-25 French Compare
v26 2025-09-25 English Compare
v25 2025-09-04 French Compare
v24 2025-09-04 English Compare
v23 2025-06-05 French Compare
v22 2025-06-05 English Compare
v21 2025-05-15 French Compare
v20 2025-05-15 English Compare

Showing 1 to 20 of 39